Oral health and dental treatment of patients with renal disease

Quintessence International

Volumn 38, Issue 3, 2007, Pages 211-219

  Vesterinen, Maarit ^a   Ruokonen, Hellevi ^a   Leivo, Tomi ^b   Honkanen, Ann Marie ^c   Honkanen, Eero ^b   Kari, Kirsti ^a   Lindqvist, Christian ^a   Meurman, Jukka H ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c Espoo Social and Health Care Center   (Finland)

Author keywords

Dental health; Dialysis; Kidney transplant; Oral health; Predialysis; Saliva

Indexed keywords

ALBUMINOID; SALIVA PROTEIN;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; DENTAL CARE; FEMALE; GINGIVA OVERGROWTH; HEALTH; HEALTH SURVEY; HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PERIODONTICS; RENAL REPLACEMENT THERAPY; XEROSTOMIA;

ADULT; ALBUMINS; DENTAL CARE FOR CHRONICALLY ILL; DMF INDEX; FEMALE; GINGIVAL OVERGROWTH; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORAL HEALTH; PERIODONTAL INDEX; RENAL DIALYSIS; SALIVARY PROTEINS; XEROSTOMIA;

EID: 33846949424     PISSN: 00336572     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Chiasson JL, Rabasa-Lhoret R. Prevention of type 2 diabetes: Insulin resistance and beta-cell function. Diabetes 2004;3:34-38.
2. Lameire N, Van Biesen W, Vanholder R. Acute renal failure. Lancet 2005;365:417-430.
3. Appel GB. Glomerular disorders. In: Bennet JC, Plum F (eds). Cecil Textbook of Medicine. Philadelphia: Saunders, 1996:572-580.
4. Ansell D, Feest T (eds). UK Renal Registry Report 2002. UK Renal Registry, Bristol, UK.
5. McDonald SP, Russ GR, Kerr PG, Collins JF. ESRD in Australia and New Zealand at the end of the millenium: A resport from the ANZDATA registry, Australia and New Zealand Dialysis and Transplant Registry. Am J Kidney Dis 2002;40:1122-1131.
6. Block G, Hulbert Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium × phosphorus product with mortality risk in chronic hemodialysis patients. A national study. Am J Kidney Dis 1998;31:607-617.
7. Eigner TL, Jastak JT, Bennett WM. Achieving oral health in patients with renal failure and renal transplants. J Am Dent Assoc 1986;113:612-616.
8. Kho H, Lee S, Chung SC, Kim YK. Oral manifestations and salivary flow rate, pH, and buffer capacity in patients with end-stage renal disease undergoing hemodialysis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:316-319.
9. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Chang HR. Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis 2000;36:1110-1114.
10. Klassen JT, Krasko BM. The dental health status of dialysis patients. J Can Dent Assoc 2002;68:34-38.
11. Kelly WH, Mirahmadi MK, Simon JH, Gorman JT. Radiographic changes of the jawbones in end-stage renal disease. Oral Surg Oral Med Oral Pathol 1980;50:372-380.
12. Galili D, Berger E, Kaufman E. Pulp narrowing in renal end stage and transplanted patients. J Endod 1991;17:442-443.
13. Nasstrom K. Dentin formation after corticosteroid treatment. A clinical study and an experimental study on rats. Swed Dent J 1996;115:1-45.
14. Locsey L, Alberth M, Mauks G. Dental management of chronic haemodialysis patients. Int Urol Nephrol 1986;18:211-213.
15. Levy HM. Dental considerations for the patient receiving dialysis for renal failure. Spec Care Dentist 1988;8:34-36.
16. Al Nowaiser A, Roberts GJ, Trompeter RS, Wilson M, Lucas VS. Oral health in children with chronic renal failure. Pediatr Nephrol 2003;18:39-45.
17. Ferguson CA, Whyman RA. Dental management of people with renal disease and renal transplants. N Z Dent J 1998;94:125-130.
18. Kerr AR. Update on renal disease for the dental practitioner. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001;92:9-16.
19. US Renal Data System, 2004. Available at: www.usrds.org/2004. Accessed 29 November 2006.
20. Proctor R, Kumar N, Stein A, Moles D, Porter S. Oral and dental aspects of chronic renal failure. J Dent Res 2005;84:199-208.
21. Meurman JH, Hakala PE. Cranial manifestations of hypophosphatasia in childhood nephrotic syndrome. Int J Oral Surg 1984;13:249-255.
22. Naugle K, Darby ML, Bauman DB, Lineberger LT, Powers R. The oral health status of individuals on renal dialysis. Ann Periodontol 1998;3:197-205.
23. Al-Wahadni A, Al-Omari MA. Dental diseases in a Jordanian population on renal dialysis. Quintessence Int 2003;34:343-347.
24. Bottomley WK, Cioffi RF, Martin AJ. Dental management of the patient treated by renal transplantation: Preoperative and postoperative considerations. J Am Dent Assoc 1972;85:1330-1335.
25. Naylor GD, Hall EH, Terezhalmy GT. The patient with chronic renal failure who is undergoing dialysis or renal transplantation: Another consideration for antimicrobial prophylaxis. Oral Surg Oral Med Oral Pathol 1988;65:116-121.
26. Stein A, Wild J. Kidney Failure Explained, ed 2. London: Class Publishing, 2002:5.
27. Jameson MD, Wiegmann TB. Principles, uses and complications of hemodialysis. Med Clin North Am 1990;74:945-960.
28. De Rossi S, Glick M. Dental considerations for the patient with renal disease receiving hemodialysis. J Am Dent Assoc 1996;127:211-219.
29. Naylor GD, Fredericks MR. Pharmacologic considerations in the dental management of the patient with disorder of the renal system. Dent Clin North Am 1996;40:665-683.
30. Werner CW, Saad TF. Prophylactic antibiotic therapy prior to dental treatment for patients with end-stage renal disease. Spec Care Dentist 1999;19:106-111.
31. Simmons NA. Recommendations for endocarditis prophylaxis. The endocarditis working party for antimicrobial chemotherapy. J Antimicrob Chemother 1993;31:437-438.
32. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794-1801.
33. Somacarrera ML, Hernandez G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671-675.
34. World Health Organization. Oral Health Surveys - Basic Methods, ed 4. Geneva: World Health Organization, 1997.
35. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J. Development of the World Health Organization (WHO) community periodontal index of treatment need (CPITN). Int Dent J 1982;32:281-291.
36. Webster D. The immediate reaction between bromcresol green and serum as measure of albumin content. Clin Chem 1977;23:663-665.
37. Lehtonen OP, Gråhn EM, Ståhlberg TH, Laitinen LA. Amount and avidity of salivary and serum antibodies against Streptococcus mutans in two groups of human subjects with different dental caries susceptibility. Infect Immun 1984;43:308-313.
38. Sreebny LM, Yu A, Green A, Valdini A. Xerostomia in diabetes mellitus. Diabetes Care 1992;15:900-904.
39. Meurman JH, Rantonen P. Salivary flow rate, buffering capacity, and yeast counts in 187 consecutive adult patients from Kuopio, Finland. Scand J Dent Res 1994;102:229-234.
40. Mellanen L, Sorsa T, Lahdevirta J, Helenius M, Kari K, Meurman JH. Salivary albumin, total protein, IgA, IgG and IgM concentrations and occurrence of some periodontopathogens in HIV-infected patients: A 2-year follow-up study. J Oral Pathol Med 2001;30:553-539.
41. Seemann R, Hagewald SJ, Sztankay V, Drews J, Bizhang M, Kage A. Levels of parotid and submandibular/sublingual salivary immunoglobulin A in response to experimental gingivitis in humans. Clin Oral Investig 2004;8:233-237.
42. Teeuw W, Bosch JA, Veerman EC, Amerongen AV. Neuroendocrine regulation of salivary IgA synthesis and secretion: Implications for oral health. Biol Chem 2004;385:1137-1146.